Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Nanoink appoints Ben Pothast chief financial officer

Abstract:
NanoInk, Inc. announced today the appointment of Ben Pothast, as its chief financial officer.

Nanoink appoints Ben Pothast chief financial officer

SKOKIE, IL | Posted on February 19th, 2008

"We are thrilled that Ben has joined the NanoInk team," said Jim Hussey, CEO of NanoInk. "Ben brings more than 20 years of diverse financial experience to NanoInk. We believe his excellent track record at some of the world's leading pharmaceutical companies will help drive our future growth."

Mr. Pothast joins NanoInk from Cambridge Major Laboratories, Inc., a privately held service-based chemistry outsourcing partner to the world's leading pharmaceutical and biotechnology companies, where he served as chief financial officer. Mr. Pothast was the first CFO in the company's history and a key member of the management team.

Previously, Mr. Pothast was vice president of planning and analysis at Ovation Pharmaceuticals, Inc., a leading biopharmaceutical company. At Ovation, Mr. Pothast was responsible for all treasury and portfolio management functions. He was a key member of the acquisition team focused on due diligence and debt and equity financing.

Prior to his work at Ovation Pharmaceuticals, Mr. Pothast served as chief financial officer of Akorn, Inc., a publicly traded specialty pharmaceutical company that develops, manufactures and markets ophthalmic and injectable products.

Mr. Pothast began his career at Ernst & Young in Chicago and is a certified public accountant. He holds a B.A. in Accounting and Business Administration from Augustana College and a Masters of Management from the Kellogg Graduate School of Business at Northwestern University.

####

About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the lifescience and semiconductor industries. With DPN, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair, and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign, and the Georgia Institute of Technology.

For more information, please click here

Contacts:
David Gutierrez
Dresner Corporate Services
NanoInk
312-780-7204


Joshua Taustein
Dresner Corporate Services
NanoInk
312-780-7219

Copyright © NanoInk, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

‘Oxford Instruments Young Nanoscientist India Award 2015’ to Prof. Arindam Ghosh April 20th, 2015

Nondestructive 3-D Imaging of Biological Cells with Sound April 20th, 2015

Advances in molecular electronics: Lights on -- molecule on: Researchers from Dresden and Konstanz succeed in light-controlled molecule switching April 20th, 2015

Yale-NUS, NUS and UT Austin researchers establish theoretical framework for graphene physics: Making strides towards using graphene to create new electronic devices April 20th, 2015

Nanomedicine

‘Oxford Instruments Young Nanoscientist India Award 2015’ to Prof. Arindam Ghosh April 20th, 2015

Iranian Female Professor Awarded UNESCO Medal in Nanoscience April 20th, 2015

Happily ever after: Scientists arrange protein-nanoparticle marriage: New biotech method could lead to development of HIV vaccine, targeted cancer treatment April 20th, 2015

Optical resonance-based biosensors designed for medical applications April 18th, 2015

Announcements

Happily ever after: Scientists arrange protein-nanoparticle marriage: New biotech method could lead to development of HIV vaccine, targeted cancer treatment April 20th, 2015

Nondestructive 3-D Imaging of Biological Cells with Sound April 20th, 2015

Advances in molecular electronics: Lights on -- molecule on: Researchers from Dresden and Konstanz succeed in light-controlled molecule switching April 20th, 2015

Yale-NUS, NUS and UT Austin researchers establish theoretical framework for graphene physics: Making strides towards using graphene to create new electronic devices April 20th, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Dais Analytic Corporation Appoints Eliza Wang to Board of Directors: Company's Newest Director Brings Expertise in Commercial and Legal Matters Both in the United States and China; Joins on the Heels of Successful Business Development Trade Mission to China April 18th, 2015

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

Nanofilm Appoints Senior Sales/Marketing Executives: Don Tecco, Director of Optical Sales, North America and Rex Talbott, Business Director Optical Products March 23rd, 2015

KIT Increases Commitment in Asia: DAAD Funds Two New Projects: Strategic Partnerships with Chinese Universities and Communi-cation Technologies Network February 22nd, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project